DOR/3TC/TDF
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DOR/3TC/TDF, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy [Phase 3]